当前位置:首页 - 行情中心 - 小方制药(603207) - 财务分析 - 现金流量表

小方制药

(603207)

  

流通市值:16.08亿  总市值:47.45亿
流通股本:5440.00万   总股本:1.61亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金416,771,775.69256,905,594.88132,307,274.52532,865,812.58
  收到的税费返还85,619.7431,390.1731,390.17114,151.92
  收到其他与经营活动有关的现金2,397,923.32877,240.84393,428.112,741,570.3
  经营活动现金流入小计419,255,318.75257,814,225.89132,732,092.8535,721,534.8
  购买商品、接受劳务支付的现金143,013,356.6973,184,112.7637,957,507.34162,742,359.96
  支付给职工以及为职工支付的现金46,896,555.8333,799,742.5215,459,429.6563,509,662.41
  支付的各项税费65,190,948.9742,362,996.1720,702,563.0262,978,949.63
  支付其他与经营活动有关的现金30,217,739.4618,208,287.745,395,421.5134,282,415.12
  经营活动现金流出小计285,318,600.95167,555,139.1979,514,921.52323,513,387.12
  经营活动产生的现金流量净额133,936,717.890,259,086.753,217,171.28212,208,147.68
二、投资活动产生的现金流量:
  收回投资收到的现金553,000,000453,000,00065,000,0002,900,000
  取得投资收益收到的现金3,660,316.663,370,913.89441,013.8989,655.7
  处置固定资产、无形资产和其他长期资产收回的现金净额110,619.47---
  收到的其他与投资活动有关的现金---3,000,000
  投资活动现金流入小计556,770,936.13456,370,913.8965,441,013.895,989,655.7
  购建固定资产、无形资产和其他长期资产支付的现金49,140,746.7530,958,225.0128,050,467.7583,942,392.06
  投资支付的现金420,000,000420,000,000-453,000,000
  投资活动现金流出小计469,140,746.75450,958,225.0128,050,467.75536,942,392.06
  投资活动产生的现金流量净额87,630,189.385,412,688.8837,390,546.14-530,952,736.36
三、筹资活动产生的现金流量:
  吸收投资收到的现金8,382,705.998,382,705.998,382,705.99472,364,872
  取得借款收到的现金--509,017.2-
  收到其他与筹资活动有关的现金1,776,039.74652,392.2-1,650,545.14
  筹资活动现金流入小计10,158,745.739,035,098.198,891,723.19474,015,417.14
  分配股利、利润或偿付利息支付的现金240,839,950.5240,839,950.5--
  支付其他与筹资活动有关的现金5,170,0005,170,0005,170,00010,956,399.21
  筹资活动现金流出小计246,009,950.5246,009,950.55,170,00010,956,399.21
  筹资活动产生的现金流量净额-235,851,204.77-236,974,852.313,721,723.19463,059,017.93
五、现金及现金等价物净增加额-14,284,297.59-141,303,076.7394,329,440.61144,314,429.25
  加:期初现金及现金等价物余额426,849,850.99426,849,850.99282,535,421.74282,535,421.74
  期末现金及现金等价物余额412,565,553.4285,546,774.26376,864,862.35426,849,850.99
补充资料:
  净利润-120,821,251.32-205,271,095.5
  资产减值准备--2,202.53-90,259.85
  固定资产和投资性房地产折旧-846,598.19-2,397,308.13
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-846,598.19-2,397,308.13
  无形资产摊销-4,675.38-9,350.76
  长期待摊费用摊销-120,333.42-234,278.37
  递延收益摊销--6,428.58--12,857.16
  财务费用--1,828,644.31-27,781.51
  投资损失----15,584.9
  递延所得税-1,255,646.57--505,020.67
  其中:递延所得税资产减少-1,255,646.57--505,020.67
  存货的减少-2,400,680.55-4,607,600.38
  经营性应收项目的减少--29,828,024.36--6,759,101.79
  经营性应付项目的增加--6,517,426.07-5,449,968.09
  现金的期末余额-285,546,774.26-426,849,850.99
  减:现金的期初余额-426,849,850.99-282,535,421.74
  现金及现金等价物的净增加额--141,303,076.73-144,314,429.25
公告日期2025-10-252025-08-262025-04-302025-04-30
审计意见(境内)标准无保留意见
TOP↑